-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Patients with functional indigestion are thought to have increased gastrointestinal sensitivity, and some suffer from functional constipation at the same time.
in the Rome IV classification, two types of indigestion syndrome were defined: upper abdominal pain syndrome and after-dinner fullness.
patients with functional indigestion also have functional constipation, which is normally caused by coordinated movements of abdominal and relaxation.
, bioremetrics can be used to effectively treat constipation caused by poor detocation disorders, such as teaching patients tips for correcting detocation.
, fiber supplementation is a conventional treatment for constipation.
study looked at whether correcting dysfunctional constipation reduced post-meal satiety in patients with functional indigestion.
researchers conducted a trial at two referral centers in Spain between June 2016 and January 2018, studying 50 patients with functional indigestion with post-meal abdominal pain syndrome, functional constipation and dysfunctional constipation.
After a two-week pre-treatment phase, patients were randomly grouped, one group learned to correct adverse detopscestion (2-3 bioneeditions combined with daily exercise instructions; n s 25) and the other group received dietary fiber supplementation (3.5 g cellulose per person/ day; n s 25) for 4 weeks.
main observations were changes in abdominal bloating after meals.
results showed that bioremetric therapy corrected detocation disorders in 19 patients, and corrected dysfunctional deficiencies reduced after-meal satiety in these patients by 22% to 1% (P.001 .009).
dietary fiber supplements do not alleviate the symptoms of these patients.
.